Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKinsey
Mallinckrodt
Medtronic
Harvard Business School

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for ATN-161


Email this page to a colleague

« Back to Dashboard

What is the drug development status for ATN-161?

ATN-161 is an investigational drug.

There have been 25 clinical trials for ATN-161. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2019.

The most common disease conditions in clinical trials are Acute Kidney Injury, HIV Infections, and Renal Insufficiency. The leading clinical trial sponsors are University of North Carolina, Chapel Hill, Attenuon, and Ablynx.

There are one hundred and forty-nine US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for ATN-161
TitleSponsorPhase
Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)Emory UniversityPhase 1
Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Phase 1
Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)Johns Hopkins UniversityPhase 1

See all ATN-161 clinical trials

Clinical Trial Summary for ATN-161

Top disease conditions for ATN-161
Top clinical trial sponsors for ATN-161

See all ATN-161 clinical trials

US Patents for ATN-161

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ATN-161 ⤷  Try it Free Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide Alkermes, Inc. (Waltham, MA) ⤷  Try it Free
ATN-161 ⤷  Try it Free Fluorinated integrin antagonists SciFluor Life Sciences, Inc. (Cambridge, MA) ⤷  Try it Free
ATN-161 ⤷  Try it Free Nonanoic and decanoic acid derivatives and uses thereof SciFluor Life Sciences, Inc. (Cambridge, MA) ⤷  Try it Free
ATN-161 ⤷  Try it Free Methods and systems for treating or preventing cancer Transdermal Biotechnology, Inc. (Meriden, CT) ⤷  Try it Free
ATN-161 ⤷  Try it Free XTEN conjugate compositions and methods of making same Amunix Operating Inc. (Mountain View, CA) ⤷  Try it Free
ATN-161 ⤷  Try it Free Fusion polypeptides comprising mucin-domain polypeptide linkers Alkermes, Inc. (Waltham, MA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ATN-161

Drugname Country Document Number Estimated Expiration Related US Patent
ATN-161 Australia AU2013271541 2032-06-08 ⤷  Try it Free
ATN-161 Australia AU2013271542 2032-06-08 ⤷  Try it Free
ATN-161 Australia AU2013271545 2032-06-08 ⤷  Try it Free
ATN-161 Australia AU2015268652 2032-06-08 ⤷  Try it Free
ATN-161 Australia AU2018200597 2032-06-08 ⤷  Try it Free
ATN-161 Canada CA2869674 2032-06-08 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
McKinsey
Mallinckrodt
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.